Recommendations for inclusion in the Authorisation List

Recommendations for inclusion in the Authorisation List

Kapslade applikationer

 

The REACH Regulation requires that ECHA recommends from the "Candidate List" priority substances for inclusion in Annex XIV (the "Authorisation List") to the European Commission, taking into account comments received from interested parties and the opinion of the Member State Committee. The European Commission finally decides, which substances will be included in Annex XIV and what the associated entries will be.

The below table includes all Candidate List substances that have been included in ECHA's draft or final recommendations for inclusion in Annex XIV. The "Status"- column indicates whether the substances have been included in a draft recommendation, recommended for inclusion or are already included in Annex XIV. Further details and documents relevant for the recommendations can be found by clicking on the "Details" next to the substances.

Substances not recommended in a given round (Status: “Not recommended in this round”) are re-assessed in subsequent rounds along with the other substances on the Candidate List. They may be included in future recommendations. Therefore, it is advisable to search the table by substance (Name/EC/CAS) to capture the most up-to-date status.
 

Recommendations for inclusion in the Authorisation List

2-(2H-benzotriazol-2-yl)-4-(tert-butyl)-6-(sec-butyl)phenol

EC No.: 253-037-1 CAS No.: 36437-37-3
Further substance information
Intrinsic property(ies) referred to in Article 57
vPvB (Article 57e)
Status
Included in Annex XIV (Authorisation List)
Recommendation round
8th recommendation
Start date of consultation
02-mar-2017
End date of consultation
02-jun-2017
Date of final recommendation
05-feb-2018
Date of inclusion in Authorisation List
06-feb-2020
Draft recommendation
Final recommendation
Draft background document
Final background document
Prioritisation results for Candidate List substances not yet recommended
Updated prioritisation results for substances included in final recommendation
Member State Committee opinion
Comments and responses to comments
Prioritisation approach
Annex XIV entries approach
Other documents
Other information
Regulation amending Annex XIV
First published
18-mar-2022